David Lukton

Array ( [id] => 9971342 [patent_doc_number] => 09018352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => 'Peptide compositions and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 12/943900 [patent_app_country] => US [patent_app_date] => 2010-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13591 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12943900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9943685 [patent_doc_number] => 08992984 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-03-31 [patent_title] => 'Protocells and their use for targeted delivery of multicomponent cargos to cancer cells' [patent_app_type] => utility [patent_app_number] => 12/909572 [patent_app_country] => US [patent_app_date] => 2010-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 9110 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12909572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9936895 [patent_doc_number] => 08986700 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Immunogenic lipopeptides comprising T-helper and cytotoxic T-lymphocyte (CTL) epitopes' [patent_app_type] => utility [patent_app_number] => 12/901457 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 26932 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12901457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754448 [patent_doc_number] => 20120027677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Prion-specific peptoid reagents' [patent_app_type] => utility [patent_app_number] => 12/924872 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 36074 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027677.pdf [firstpage_image] =>[orig_patent_app_number] => 12924872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10548373 [patent_doc_number] => 09272983 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-01 [patent_title] => '2-amino-3-methyl-hex-5-enoic acid and its use in the production of peptides including bacitracins' [patent_app_type] => utility [patent_app_number] => 13/502144 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 2954 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6025768 [patent_doc_number] => 20110053839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'GLP-1 Derivatives II' [patent_app_type] => utility [patent_app_number] => 12/861511 [patent_app_country] => US [patent_app_date] => 2010-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19421 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053839.pdf [firstpage_image] =>[orig_patent_app_number] => 12861511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080260 [patent_doc_number] => 20110142901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'SUSTAINED RELEASE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/860470 [patent_app_country] => US [patent_app_date] => 2010-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12027 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142901.pdf [firstpage_image] =>[orig_patent_app_number] => 12860470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253331 [patent_doc_number] => 20120157660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/859204 [patent_app_country] => US [patent_app_date] => 2010-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 21994 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157660.pdf [firstpage_image] =>[orig_patent_app_number] => 12859204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313790 [patent_doc_number] => 20120190814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'Thiol Protecting Group' [patent_app_type] => utility [patent_app_number] => 13/389616 [patent_app_country] => US [patent_app_date] => 2010-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22845 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6025812 [patent_doc_number] => 20110053856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'METABOLITE DERIVATIVES OF THE HDAC INHIBITOR FK228' [patent_app_type] => utility [patent_app_number] => 12/845658 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8075 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053856.pdf [firstpage_image] =>[orig_patent_app_number] => 12845658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6583294 [patent_doc_number] => 20100291199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Compositions and Methods For The Treatment and Prevention of Disease' [patent_app_type] => utility [patent_app_number] => 12/842655 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10118 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291199.pdf [firstpage_image] =>[orig_patent_app_number] => 12842655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494823 [patent_doc_number] => 20100286033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'NEW CYCLIC PEPTIDE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/840488 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31737 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286033.pdf [firstpage_image] =>[orig_patent_app_number] => 12840488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071498 [patent_doc_number] => 20110046349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'PROCESS FOR THE PRODUCTION OF EXENATIDE AND OF AN EXENATIDE ANALOGUE' [patent_app_type] => utility [patent_app_number] => 12/836411 [patent_app_country] => US [patent_app_date] => 2010-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33039 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046349.pdf [firstpage_image] =>[orig_patent_app_number] => 12836411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995299 [patent_doc_number] => 08519183 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Uses for amino acid anticonvulsants' [patent_app_type] => utility [patent_app_number] => 12/829160 [patent_app_country] => US [patent_app_date] => 2010-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14836 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12829160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063737 [patent_doc_number] => 20110245155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'TEMPLATE-FIXED BETA-HAIRPIN PEPTIDOMIMETICS WITH CXCR4 ANTAGONIZING ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/828998 [patent_app_country] => US [patent_app_date] => 2010-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52401 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245155.pdf [firstpage_image] =>[orig_patent_app_number] => 12828998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236206 [patent_doc_number] => 20100267616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'ACUTE RESPIRATORY SYNDROMES' [patent_app_type] => utility [patent_app_number] => 12/828168 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1224 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267616.pdf [firstpage_image] =>[orig_patent_app_number] => 12828168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6505319 [patent_doc_number] => 20100260822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'SURFACE PROTECTION OF EXPOSED BIOLOGICAL TISSUES' [patent_app_type] => utility [patent_app_number] => 12/822809 [patent_app_country] => US [patent_app_date] => 2010-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5577 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260822.pdf [firstpage_image] =>[orig_patent_app_number] => 12822809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9245532 [patent_doc_number] => 08609813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Prodrug anti-cancer therapy' [patent_app_type] => utility [patent_app_number] => 12/820827 [patent_app_country] => US [patent_app_date] => 2010-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 6639 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12820827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571993 [patent_doc_number] => 08338641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Method for treating atypical facial pain' [patent_app_type] => utility [patent_app_number] => 12/816753 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7947 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12816753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239376 [patent_doc_number] => 08604168 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders' [patent_app_type] => utility [patent_app_number] => 12/813988 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 30167 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12813988 [rel_patent_id] =>[rel_patent_doc_number] =>)